-An in vivo study of the tissue and cellular distribution of isotopically-labelled chlorambucil (586 mCi/mmole) in rats bearing a chlorambucil-sensitive or chlorambucil-resistant Yoshida ascites sarcoma has therefore been made in an attempt to elucidate the metabolic fate and mode of action of this drug.
MATERIALS AND METHODSFull details of tumour transplantation techniques have been described previously (Harrap and Hill, 1969). Tritium-labelled chlorambuc'll 4-(4-di-(2-chloroethyl)amino-3,5_3H phenyl)butyric acid was synthesized by the reductive tritiation of the iodinated derivative in the Chester Beatty Research Institute (Jarman, unpublished work, 1970). The drug was administered subcutaneously to animals bearing the Yoshida ascites sarcoma in ascitic form at a dose of 8 mg./kg. body weight on the. fourth day following tumour transplantation because this dose induced complete regression of the sensitive tumour but was without effect on the growth rate of the resistant tumour (Harrap. and Hill, 1969).